Shenzhen Salubris Pharmaceuticals Co., Ltd.

SZSE:002294 주식 보고서

시가총액: CN¥36.8b

Shenzhen Salubris Pharmaceuticals 관리

관리 기준 확인 4/4

Shenzhen Salubris Pharmaceuticals CEO는 Jie Yan, Sep2022 에 임명되었습니다 의 임기는 2.17 년입니다. 는 CN¥ 4.40M 가치에 해당하는 회사 주식의 0.012% 직접 소유합니다. 4.40M. 경영진과 이사회의 평균 재임 기간은 각각 7.9 년과 7.7 년입니다.

주요 정보

Jie Yan

최고 경영자

CN¥1.7m

총 보상

CEO 급여 비율n/a
CEO 임기2.2yrs
CEO 소유권0.01%
경영진 평균 재임 기간7.9yrs
이사회 평균 재임 기간7.7yrs

최근 관리 업데이트

Recent updates

These 4 Measures Indicate That Shenzhen Salubris Pharmaceuticals (SZSE:002294) Is Using Debt Safely

Nov 11
These 4 Measures Indicate That Shenzhen Salubris Pharmaceuticals (SZSE:002294) Is Using Debt Safely

We Think That There Are More Issues For Shenzhen Salubris Pharmaceuticals (SZSE:002294) Than Just Sluggish Earnings

Sep 02
We Think That There Are More Issues For Shenzhen Salubris Pharmaceuticals (SZSE:002294) Than Just Sluggish Earnings

What Shenzhen Salubris Pharmaceuticals Co., Ltd.'s (SZSE:002294) P/E Is Not Telling You

Aug 23
What Shenzhen Salubris Pharmaceuticals Co., Ltd.'s (SZSE:002294) P/E Is Not Telling You

Are Investors Undervaluing Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294) By 21%?

Aug 02
Are Investors Undervaluing Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294) By 21%?

Shenzhen Salubris Pharmaceuticals Co., Ltd.'s (SZSE:002294) Share Price Not Quite Adding Up

May 22
Shenzhen Salubris Pharmaceuticals Co., Ltd.'s (SZSE:002294) Share Price Not Quite Adding Up

A Look At The Fair Value Of Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294)

Apr 17
A Look At The Fair Value Of Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294)

Is Shenzhen Salubris Pharmaceuticals (SZSE:002294) A Risky Investment?

Feb 28
Is Shenzhen Salubris Pharmaceuticals (SZSE:002294) A Risky Investment?

CEO

Jie Yan (52 yo)

2.2yrs

테뉴어

CN¥1,744,500

보상

Mr. Jie Yan had been Deputy General Manager at Shenzhen Salubris Pharmaceuticals Co., Ltd. since October 11, 2013 until September 23, 2022 and has been its Non- Independent Director since February 9, 2018...


리더십 팀

이름위치테뉴어보상소유권
Jie Yan
GM & Director2.2yrsCN¥1.74m0.012%
CN¥ 4.4m
Yun Kong
CFO, Accounting Supervisor & Financial Manager2.9yrsCN¥1.31m데이터 없음
Ping Chen
Deputy General Manager17.4yrsCN¥963.70k데이터 없음
Jianfeng Yang
Secretary of the Board of Directors & Non Independent Director17.1yrsCN¥936.70k0.011%
CN¥ 3.9m
Song Ping Zhao
Deputy General Manager7.9yrsCN¥1.05m0.0075%
CN¥ 2.8m
Xie Heng
Chief Medical Officerno data데이터 없음데이터 없음

7.9yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 관리: 002294 의 관리팀은 노련하고 경험 (평균 재직 기간 7.9 년)입니다.


이사회 구성원

이름위치테뉴어보상소유권
Jie Yan
GM & Director6.8yrsCN¥1.74m0.012%
CN¥ 4.4m
Jianfeng Yang
Secretary of the Board of Directors & Non Independent Director14.3yrsCN¥936.70k0.011%
CN¥ 3.9m
Chenghai Ye
Director17.4yrs데이터 없음데이터 없음
Sing Ye
Chairman17.4yrsCN¥1.55m데이터 없음
Houjia Zhu
Independent Director3.6yrsCN¥120.00k데이터 없음
Laiping Liu
Independent Director4.8yrsCN¥120.00k데이터 없음
Aizhen Li
Chairman of the Supervisory Board7.9yrs데이터 없음데이터 없음
Xuegong Wang
Independent Director2.9yrsCN¥120.00k데이터 없음
Yangbing Li
Supervisor7.7yrs데이터 없음데이터 없음

7.7yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 이사회: 002294 의 이사회경험(평균 재직 기간 7.7 년)으로 간주됩니다.